首页> The international journal of neuropsychopharmacology> Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.

Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.

导出 OA

翻译打印收藏纠错

第一作者： Michel,Nijs

第一单位： Janssen Research and Development, LLC, Department of Global Analytics - Neuroscience, Titusville.

作者： Michel,Nijs ^[1] ; Ewa,Wajs ^[2] ; Leah,Aluisio ^[3] ; Ibrahim,Turkoz ^[4] ; Ella,Daly ^[5] ; Adam,Janik ^[3] ; Stephane,Borentain ^[5] ; Jaskaran B,Singh ^[3] ; Allitia,DiBernardo ^[6] ; Frank,Wiegand ^[5]

作者单位： Janssen Research and Development, LLC, Department of Global Analytics - Neuroscience, Titusville. ^[1] Janssen Research and Development, Belgium, Department of Neuroscience, Beerse, Belgium. ^[2] Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA. ^[3] Janssen Research and Development, LLC, Department of Statistics & Decision Sciences, Titusville, NJ. ^[4] Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ. ^[5] Janssen Research and Development, France, Department of Clinical Medical Affairs, Issy-les-Moulineaux, France. ^[6]

关键词 Esketamine dosing s-ketamine treatment-resistant depression